TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
HUMA

Humacyte Inc

Healthcare · Biotechnology

0.5856$ +1.8% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet HUMA
Line item 2019 2020 2021 2022 2023 2024 2025
-36.8% +168.6% -28.7% -37.2% +7.5% -15.6%
-56.3% +453.3% -32.8% -46.0% -42.5% +41.7%
-57.4% +444.7% -31.1% -46.3% -44.1% +12.4%
-57.4% +464.8% -32.6% -47.0% -44.1% +12.4%
-81.2% +55.8% -82.4% -100.0%
+0.0% +0.0% -3,100,100.0%
-11.5% -46.3% -14.3%
-1.3% +356.3% -46.8% +31.2% +66.2% -40.6%
+3.6% -1.6% +77.2% -5.8% +8.2% -7.9%
+37.5% -52.0% +436.9% -76.5% +13.9% -16.8%
-30.5% -7.9% -23.8% +306.9% -30.8% +20.4%
+3,228.6% -25.7% +89.8%
-46.5% +72.9% -4.3% -88.4% -488.8%
-87.9% +221.1% +157.8% +0.4% +14.6% +33.5%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?